The lower MMP8 levels observed in plasma of patients with inflammatory breast cancer, which may reflect higher levels in the tumour, are consistent with a pro-tumorigenic role of MMP8 and suggest that MMP8 may be implicated in the inflammation-dependent mechanisms of this aggressive breast tumour type. The gene discussed is MMP8; the disease is neoplasm.